Machine Learning-Based Prediction Model for Predicting the Effect of the Serum γKlotho Level on Susceptibility to

Zi-Tong Guo1, Xiao-Lin Yu2, Hui Cheng2

  • 1Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China.

Insights

Serum γKlotho levels are a novel biomarker positively related to coronary heart disease (CHD) risk. A machine learning model, specifically Random Forest (RF), shows promise for predicting CHD risk in clinical settings.

Area of Science:

  • Cardiology
  • Biomarkers
  • Machine Learning in Healthcare

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Identifying novel biomarkers and improving predictive models for CHD risk is crucial for early intervention.
  • Serum γKlotho has emerged as a potential factor influencing cardiovascular health.

Purpose of the Study:

  • To investigate the association between serum γKlotho levels and the risk of developing coronary heart disease (CHD).
  • To develop and validate a machine learning (ML) model for predicting CHD risk.
  • To evaluate the clinical utility of serum γKlotho as a biomarker for CHD.

Main Methods:

  • Analysis of 1435 subjects, randomly assigned to training (70%) and validation (30%) groups.
  • Utilized univariate and least absolute shrinkage and selection operator (LASSO) regression to identify independent risk factors for CHD.
  • Developed and evaluated nine ML models, selecting the best performing model (Random Forest - RF) for validation using decision curve analysis (DCA).

Main Results:

  • Key factors independently associated with CHD risk include age, serum γKlotho levels, LDL-C, sex, diabetes, hypertension, and smoking status.
  • The Random Forest (RF) model demonstrated superior performance compared to eight other ML models.
  • Validation confirmed the promising clinical applicability of the developed RF model for CHD risk prediction.

Conclusions:

  • Serum γKlotho is a novel biomarker positively correlated with coronary heart disease (CHD) risk.
  • The Random Forest (RF) model provides a robust and accurate method for predicting CHD risk.
  • The RF model is well-suited for clinical application in assessing and managing CHD risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
298
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
352
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222